{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:44:20Z","timestamp":1782981860815,"version":"3.54.5"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>We have previously outlined functional interactions, including feedback cycles, between several of the gene products implicated in the pathogenesis of Alzheimer's disease. A number of Alzheimer-related stressors induce neuronal expression of apolipoprotein E (ApoE), \u03b2-amyloid precursor protein (\u03b2APP), and fragments of the latter such as amyloid \u03b2-peptide (A\u03b2) and secreted APP (sAPP). These stressors include interleukin-1 (IL-1)-mediated neuroinflammation and glutamate-mediated excitotoxicity. Such circumstances are especially powerful when they transpire in the context of an <jats:italic>APOE<\/jats:italic> \u03b54 allele.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Semi-quantitative immunofluorescence imaging was used to analyze rat brains implanted with IL-1\u03b2 slow-release pellets, sham pellets, or no pellets. Primary neuronal or NT2 cell cultures were treated with IL-1\u03b2, glutamate, A\u03b2, or sAPP; relative levels of ApoE mRNA and protein were measured by RT-PCR, qRT-PCR, and western immunoblot analysis. Cultures were also treated with inhibitors of multi-lineage kinases--in particular MAPK-p38 (SB203580), ERK (U0126), or JNK (SP600125)--prior to exposure of cultures to IL-1\u03b2, A\u03b2, sAPP, or glutamate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Immunofluorescence of tissue sections from pellet-implanted rats showed that IL-1\u03b2 induces expression of \u03b2APP, IL-1\u03b1, and ApoE; the latter was confirmed by western blot analysis. These protein changes were mirrored by increases in their mRNAs, as well as in those encoding IL-1\u03b2, IL-1\u03b2-converting enzyme (ICE), and tumor necrosis factor (TNF). IL-1\u03b2 also increased ApoE expression in neuronal cultures. It stimulated release of sAPP and glutamate in these cultures too, and both of these agents--as well as A\u03b2--stimulated ApoE expression themselves, suggesting that they may contribute to the effect of IL-1\u03b2 on ApoE levels. Inhibitors of MAPK-p38, ERK, and JNK inhibited ApoE induction by all these agents except glutamate, which was sensitive only to inhibitors of ERK and JNK.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Conditions of glial activation and hyperexcitation can elevate proinflammatory cytokines, ApoE, glutamate, \u03b2APP, and its secreted fragments. Because each of these factors promotes glial activation and neuronal hyperexcitation, these relationships have the potential to sustain self-propagating neurodegenerative cycles that could culminate in a progressive neurodegenerative disorder such as Alzheimer's disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-2094-8-175","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T07:35:24Z","timestamp":1324020924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors"],"prefix":"10.1186","volume":"8","author":[{"given":"Ling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orwa","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Mrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Sue T","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W","family":"Barger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"506_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1469-8749.2005.tb01042.x","volume":"47","author":"JA Blackman","year":"2005","unstructured":"Blackman JA, Worley G, Strittmatter WJ: Apolipoprotein E and brain injury: implications for children. Dev Med Child Neurol. 2005, 47: 64-70.","journal-title":"Dev Med Child Neurol"},{"key":"506_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuron.2005.08.001","volume":"47","author":"G D'Arcangelo","year":"2005","unstructured":"D'Arcangelo G: Apoer2: a reelin receptor to remember. Neuron. 2005, 47: 471-473. 10.1016\/j.neuron.2005.08.001.","journal-title":"Neuron"},{"key":"506_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0896-6273(00)80860-0","volume":"24","author":"G D'Arcangelo","year":"1999","unstructured":"D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T: Reelin is a ligand for lipoprotein receptors. Neuron. 1999, 24: 471-479. 10.1016\/S0896-6273(00)80860-0.","journal-title":"Neuron"},{"key":"506_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00041433-200204000-00002","volume":"13","author":"WJ Strittmatter","year":"2002","unstructured":"Strittmatter WJ, Bova Hill C: Molecular biology of apolipoprotein E. Curr Opin Lipidol. 2002, 13: 119-123. 10.1097\/00041433-200204000-00002.","journal-title":"Curr Opin Lipidol"},{"key":"506_CR5","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","volume":"91","author":"WJ Strittmatter","year":"1994","unstructured":"Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD: Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA. 1994, 91: 11183-11186. 10.1073\/pnas.91.23.11183.","journal-title":"Proc Natl Acad Sci USA"},{"key":"506_CR6","volume-title":"Nat Rev Neurosci","author":"G Bu","year":"2009","unstructured":"Bu G: Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009"},{"key":"506_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","volume":"6","author":"U Boschert","year":"1999","unstructured":"Boschert U, Merlo-Pich E, Higgins G, Roses AD, Catsicas S: Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol Dis. 1999, 6: 508-514. 10.1006\/nbdi.1999.0251.","journal-title":"Neurobiol Dis"},{"key":"506_CR8","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y: Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006, 26: 4985-4994. 10.1523\/JNEUROSCI.5476-05.2006.","journal-title":"J Neurosci"},{"key":"506_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1212\/WNL.55.4.480","volume":"55","author":"Y Du","year":"2000","unstructured":"Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmuller F, Muller U, Kurz A, Zimmer R, Evans RM, et al: Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology. 2000, 55: 480-483.","journal-title":"Neurology"},{"key":"506_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N","volume":"47","author":"LM Grimaldi","year":"2000","unstructured":"Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, et al: Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol. 2000, 47: 361-365. 10.1002\/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N.","journal-title":"Ann Neurol"},{"key":"506_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G","volume":"47","author":"JA Nicoll","year":"2000","unstructured":"Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, et al: Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 2000, 47: 365-368. 10.1002\/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G.","journal-title":"Ann Neurol"},{"key":"506_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0304-3940(00)01487-7","volume":"293","author":"GW Rebeck","year":"2000","unstructured":"Rebeck GW: Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett. 2000, 293: 75-77. 10.1016\/S0304-3940(00)01487-7.","journal-title":"Neurosci Lett"},{"key":"506_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE: Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008, 9: 768-778. 10.1038\/nrn2494.","journal-title":"Nat Rev Neurosci"},{"key":"506_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0304-3940(94)90066-3","volume":"176","author":"WS Griffin","year":"1994","unstructured":"Griffin WS, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW: Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci Lett. 1994, 176: 133-136. 10.1016\/0304-3940(94)90066-3.","journal-title":"Neurosci Lett"},{"key":"506_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00005072-199405000-00003","volume":"53","author":"LC Stanley","year":"1994","unstructured":"Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang S, Marshak DR, Nelson SJ, Griffin WS: Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol. 1994, 53: 231-238. 10.1097\/00005072-199405000-00003.","journal-title":"J Neuropathol Exp Neurol"},{"key":"506_CR16","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1046\/j.1471-4159.1994.63051872.x","volume":"63","author":"JG Sheng","year":"1994","unstructured":"Sheng JG, Boop FA, Mrak RE, Griffin WS: Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem. 1994, 63: 1872-1879.","journal-title":"J Neurochem"},{"key":"506_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1471-4159.1995.65010228.x","volume":"65","author":"WS Griffin","year":"1995","unstructured":"Griffin WS, Yeralan O, Sheng JG, Boop FA, Mrak RE, Rovnaghi CR, Burnett BA, Feoktistova A, Van Eldik LJ: Overexpression of the neurotrophic cytokine S100 beta in human temporal lobe epilepsy. J Neurochem. 1995, 65: 228-233.","journal-title":"J Neurochem"},{"key":"506_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/BF00294177","volume":"87","author":"IR Mackenzie","year":"1994","unstructured":"Mackenzie IR, Miller LA: Senile plaques in temporal lobe epilepsy. Acta Neuropathol (Berl). 1994, 87: 504-510. 10.1007\/BF00294177.","journal-title":"Acta Neuropathol (Berl)"},{"key":"506_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbi.2008.03.009","volume":"22","author":"A Vezzani","year":"2008","unstructured":"Vezzani A, Balosso S, Ravizza T: The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun. 2008, 22: 797-803. 10.1016\/j.bbi.2008.03.009.","journal-title":"Brain Behav Immun"},{"key":"506_CR20","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 1989, 86: 7611-7615. 10.1073\/pnas.86.19.7611.","journal-title":"Proc Natl Acad Sci USA"},{"key":"506_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s004010050792","volume":"95","author":"JG Sheng","year":"1998","unstructured":"Sheng JG, Mrak RE, Griffin WS: Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl). 1998, 95: 229-234. 10.1007\/s004010050792.","journal-title":"Acta Neuropathol (Berl)"},{"key":"506_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1474-9728.2004.00101.x","volume":"3","author":"I Blasko","year":"2004","unstructured":"Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B: How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell. 2004, 3: 169-176. 10.1111\/j.1474-9728.2004.00101.x.","journal-title":"Aging Cell"},{"key":"506_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10522-005-6039-9","volume":"7","author":"JR Gee","year":"2006","unstructured":"Gee JR, Ding Q, Keller JN: Age-related alterations of Apolipoprotein E and interleukin-1beta in the aging brain. Biogerontology. 2006, 7: 69-79. 10.1007\/s10522-005-6039-9.","journal-title":"Biogerontology"},{"key":"506_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","volume":"65","author":"MM Esiri","year":"1998","unstructured":"Esiri MM, Biddolph SC, Morris CS: Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry. 1998, 65: 29-33. 10.1136\/jnnp.65.1.29.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"506_CR25","first-page":"96","volume":"66","author":"DI Graham","year":"1996","unstructured":"Graham DI, Gentleman SM, Nicoll JA, Royston MC, McKenzie JE, Roberts GW, Griffin WS: Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. Acta Neurochir Suppl. 1996, 66: 96-102.","journal-title":"Acta Neurochir Suppl"},{"key":"506_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/ana.410410317","volume":"41","author":"GK Gouras","year":"1997","unstructured":"Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S: Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol. 1997, 41: 402-404. 10.1002\/ana.410410317.","journal-title":"Ann Neurol"},{"key":"506_CR27","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1093\/brain\/awh595","volume":"128","author":"GM Teasdale","year":"2005","unstructured":"Teasdale GM, Murray GD, Nicoll JA: The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain. 2005, 128: 2556-2561. 10.1093\/brain\/awh595.","journal-title":"Brain"},{"key":"506_CR28","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/2677","volume":"4","author":"EH Corder","year":"1998","unstructured":"Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C: HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med. 1998, 4: 1182-1184. 10.1038\/2677.","journal-title":"Nat Med"},{"key":"506_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ana.410430316","volume":"43","author":"VP Prasher","year":"1998","unstructured":"Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC: Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol. 1998, 43: 380-383. 10.1002\/ana.410430316.","journal-title":"Ann Neurol"},{"key":"506_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","volume":"17","author":"JG Sheng","year":"1996","unstructured":"Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WS: In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging. 1996, 17: 761-766. 10.1016\/0197-4580(96)00104-2.","journal-title":"Neurobiol Aging"},{"key":"506_CR31","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/42257","volume":"388","author":"SW Barger","year":"1997","unstructured":"Barger SW, Harmon AD: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 1997, 388: 878-881. 10.1038\/42257.","journal-title":"Nature"},{"key":"506_CR32","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2990.1996.tb01112.x","volume":"22","author":"JG Sheng","year":"1996","unstructured":"Sheng JG, Mrak RE, Griffin WS: Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression. Neuropathol Appl Neurobiol. 1996, 22: 334-341. 10.1111\/j.1365-2990.1996.tb01112.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"506_CR33","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, et al: Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 1999, 96: 15233-15238. 10.1073\/pnas.96.26.15233.","journal-title":"Proc Natl Acad Sci USA"},{"key":"506_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-2094-3-5","volume":"3","author":"WS Griffin","year":"2006","unstructured":"Griffin WS, Liu L, Li Y, Mrak RE, Barger SW: Interleukin-1 mediates Alzheimer and Lewy body pathologies. J Neuroinflammation. 2006, 3: 5-10.1186\/1742-2094-3-5.","journal-title":"J Neuroinflammation"},{"key":"506_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/NEN.0b013e318180ec47","volume":"67","author":"SW Barger","year":"2008","unstructured":"Barger SW, DeWall KM, Liu L, Mrak RE, Griffin WS: Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies. J Neuropathol Exp Neurol. 2008, 67: 773-783. 10.1097\/NEN.0b013e318180ec47.","journal-title":"J Neuropathol Exp Neurol"},{"key":"506_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbr.2007.08.003","volume":"186","author":"Y Senechal","year":"2008","unstructured":"Senechal Y, Kelly PH, Dev KK: Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning. Behav Brain Res. 2008, 186: 126-132. 10.1016\/j.bbr.2007.08.003.","journal-title":"Behav Brain Res"},{"key":"506_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-4522(98)00410-2","volume":"90","author":"GR Dawson","year":"1999","unstructured":"Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O'Dowd G, Bowery BJ, Boyce S, Trumbauer ME, Chen HY, et al: Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience. 1999, 90: 1-13. 10.1016\/S0306-4522(98)00410-2.","journal-title":"Neuroscience"},{"key":"506_CR38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","volume":"77","author":"MP Mattson","year":"1997","unstructured":"Mattson MP: Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev. 1997, 77: 1081-1132.","journal-title":"Physiol Rev"},{"key":"506_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00001756-199803090-00010","volume":"9","author":"DT Laskowitz","year":"1998","unstructured":"Laskowitz DT, Matthew WD, Bennett ER, Schmechel D, Herbstreith MH, Goel S, McMillian MK: Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport. 1998, 9: 615-618. 10.1097\/00001756-199803090-00010.","journal-title":"Neuroreport"},{"key":"506_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0165-5728(00)00459-8","volume":"114","author":"JR Lynch","year":"2001","unstructured":"Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT: Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J Neuroimmunol. 2001, 114: 107-113. 10.1016\/S0165-5728(00)00459-8.","journal-title":"J Neuroimmunol"},{"key":"506_CR41","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/01.STR.0000020124.61998.BC","volume":"33","author":"M Koistinaho","year":"2002","unstructured":"Koistinaho M, Kettunen MI, Holtzman DM, Kauppinen RA, Higgins LS, Koistinaho J: Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility. Stroke. 2002, 33: 1905-1910. 10.1161\/01.STR.0000020124.61998.BC.","journal-title":"Stroke"},{"key":"506_CR42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1523\/JNEUROSCI.20-01-00149.2000","volume":"20","author":"Y Li","year":"2000","unstructured":"Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, Griffin WS: Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J Neurosci. 2000, 20: 149-155.","journal-title":"J Neurosci"},{"key":"506_CR43","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1046\/j.1471-4159.1998.71041421.x","volume":"71","author":"Y Li","year":"1998","unstructured":"Li Y, Wang J, Sheng JG, Liu L, Barger SW, Jones RA, Van Eldik LJ, Mrak RE, Griffin WS: S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem. 1998, 71: 1421-1428.","journal-title":"J Neurochem"},{"key":"506_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-2094-1-2","volume":"1","author":"SZ Wu","year":"2004","unstructured":"Wu SZ, Bodles AM, Porter MM, Griffin WS, Basile AS, Barger SW: Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J Neuroinflammation. 2004, 1: 2-10.1186\/1742-2094-1-2.","journal-title":"J Neuroinflammation"},{"key":"506_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jnr.1208","volume":"66","author":"Y Li","year":"2001","unstructured":"Li Y, Liu L, Barger SW, Mrak RE, Griffin WS: Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res. 2001, 66: 163-170. 10.1002\/jnr.1208.","journal-title":"J Neurosci Res"},{"key":"506_CR46","doi-asserted-by":"publisher","first-page":"10075","DOI":"10.1073\/pnas.89.21.10075","volume":"89","author":"JD Buxbaum","year":"1992","unstructured":"Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P: Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta\/A4 amyloid protein precursor. Proc Natl Acad Sci USA. 1992, 89: 10075-10078. 10.1073\/pnas.89.21.10075.","journal-title":"Proc Natl Acad Sci USA"},{"key":"506_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0197-0186(01)00041-9","volume":"39","author":"JG Sheng","year":"2001","unstructured":"Sheng JG, Jones RA, Zhou XQ, McGinness JM, Van Eldik LJ, Mrak RE, Griffin WS: Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem Int. 2001, 39: 341-348. 10.1016\/S0197-0186(01)00041-9.","journal-title":"Neurochem Int"},{"key":"506_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"WS Griffin","year":"1998","unstructured":"Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE: Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 1998, 8: 65-72.","journal-title":"Brain Pathol"},{"key":"506_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00005072-199603000-00002","volume":"55","author":"RE Mrak","year":"1996","unstructured":"Mrak RE, Sheng JG, Griffin WS: Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol. 1996, 55: 273-279. 10.1097\/00005072-199603000-00002.","journal-title":"J Neuropathol Exp Neurol"},{"key":"506_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-5728(98)00188-X","volume":"93","author":"L Meda","year":"1999","unstructured":"Meda L, Baron P, Prat E, Scarpini E, Scarlato G, Cassatella MA, Rossi F: Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol. 1999, 93: 45-52. 10.1016\/S0165-5728(98)00188-X.","journal-title":"J Neuroimmunol"},{"key":"506_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1046\/j.1471-4159.1997.69010060.x","volume":"69","author":"SW Barger","year":"1997","unstructured":"Barger SW, Mattson MP: Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein. J Neurochem. 1997, 69: 60-67.","journal-title":"J Neurochem"},{"key":"506_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/156720507781077241","volume":"4","author":"S Wu","year":"2007","unstructured":"Wu S, Basile AS, Barger SW: Induction of serine racemase expression and D-serine release from microglia by secreted amyloid precursor protein (sAPP). Curr Alzheimer Res. 2007, 4: 243-251.","journal-title":"Curr Alzheimer Res"},{"key":"506_CR53","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993, 90: 9649-9653. 10.1073\/pnas.90.20.9649.","journal-title":"Proc Natl Acad Sci USA"},{"key":"506_CR54","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B: Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994, 145: 1030-1035.","journal-title":"Am J Pathol"},{"key":"506_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0006-8993(97)00411-3","volume":"763","author":"K Horsburgh","year":"1997","unstructured":"Horsburgh K, Fitzpatrick M, Nilsen M, Nicoll JA: Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat. Brain Res. 1997, 763: 103-110. 10.1016\/S0006-8993(97)00411-3.","journal-title":"Brain Res"},{"key":"506_CR56","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/01.STR.0000100157.88508.2F","volume":"34","author":"A Kay","year":"2003","unstructured":"Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J: Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke. 2003, 34: e240-243. 10.1161\/01.STR.0000100157.88508.2F.","journal-title":"Stroke"},{"key":"506_CR57","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1093\/hmg\/6.12.2151","volume":"6","author":"JC Lambert","year":"1997","unstructured":"Lambert JC, Perez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC: Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet. 1997, 6: 2151-2154. 10.1093\/hmg\/6.12.2151.","journal-title":"Hum Mol Genet"},{"key":"506_CR58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1023\/A:1007516210548","volume":"25","author":"C Hesse","year":"2000","unstructured":"Hesse C, Larsson H, Fredman P, Minthon L, Andreasen N, Davidsson P, Blennow K: Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem Res. 2000, 25: 511-517. 10.1023\/A:1007516210548.","journal-title":"Neurochem Res"},{"key":"506_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","volume":"183","author":"H Fukumoto","year":"2003","unstructured":"Fukumoto H, Ingelsson M, Garevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC: APOE epsilon 3\/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Exp Neurol. 2003, 183: 249-253. 10.1016\/S0014-4886(03)00088-8.","journal-title":"Exp Neurol"},{"key":"506_CR60","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/hmg\/ddh299","volume":"13","author":"NJ Bray","year":"2004","unstructured":"Bray NJ, Jehu L, Moskvina V, Buxbaum JD, Dracheva S, Haroutunian V, Williams J, Buckland PR, Owen MJ, O'Donovan MC: Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Hum Mol Genet. 2004, 13: 2885-2892. 10.1093\/hmg\/ddh299.","journal-title":"Hum Mol Genet"},{"key":"506_CR61","volume-title":"Neurobiol Aging","author":"T Darreh-Shori","year":"2009","unstructured":"Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A: The apolipoprotein E varepsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiol Aging. 2009"},{"key":"506_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0006-8993(99)01894-6","volume":"843","author":"U Beffert","year":"1999","unstructured":"Beffert U, Cohn JS, Petit-Turcotte C, Tremblay M, Aumont N, Ramassamy C, Davignon J, Poirier J: Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res. 1999, 843: 87-94. 10.1016\/S0006-8993(99)01894-6.","journal-title":"Brain Res"},{"key":"506_CR63","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0169-328X(95)00097-C","volume":"33","author":"P Bertrand","year":"1995","unstructured":"Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM: Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res Mol Brain Res. 1995, 33: 174-178.","journal-title":"Brain Res Mol Brain Res"},{"key":"506_CR64","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM: The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009, 63: 287-303. 10.1016\/j.neuron.2009.06.026.","journal-title":"Neuron"},{"key":"506_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1385\/JMN:23:3:205","volume":"23","author":"L Guo","year":"2004","unstructured":"Guo L, LaDu MJ, Van Eldik LJ: A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity. J Mol Neurosci. 2004, 23: 205-212. 10.1385\/JMN:23:3:205.","journal-title":"J Mol Neurosci"},{"key":"506_CR66","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0197-4580(02)00016-7","volume":"23","author":"CA Colton","year":"2002","unstructured":"Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, Saunders AM, Schmechel DE, Rasheed K, Vitek MP: APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging. 2002, 23: 777-785. 10.1016\/S0197-4580(02)00016-7.","journal-title":"Neurobiol Aging"},{"key":"506_CR67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0306-4522(03)00436-6","volume":"121","author":"Y Ezra","year":"2003","unstructured":"Ezra Y, Oron L, Moskovich L, Roses AD, Beni SM, Shohami E, Michaelson DM: Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury. Neuroscience. 2003, 121: 315-325. 10.1016\/S0306-4522(03)00436-6.","journal-title":"Neuroscience"},{"key":"506_CR68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1471-4159.2004.03007.x","volume":"93","author":"HS Hoe","year":"2005","unstructured":"Hoe HS, Harris DC, Rebeck GW: Multiple pathways of apolipoprotein E signaling in primary neurons. J Neurochem. 2005, 93: 145-155. 10.1111\/j.1471-4159.2004.03007.x.","journal-title":"J Neurochem"},{"key":"506_CR69","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1074\/jbc.M005070200","volume":"276","author":"N Ohkubo","year":"2001","unstructured":"Ohkubo N, Mitsuda N, Tamatani M, Yamaguchi A, Lee YD, Ogihara T, Vitek MP, Tohyama M: Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J Biol Chem. 2001, 276: 3046-3053. 10.1074\/jbc.M005070200.","journal-title":"J Biol Chem"},{"key":"506_CR70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","volume":"5","author":"GE Hardingham","year":"2002","unstructured":"Hardingham GE, Fukunaga Y, Bading H: Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002, 5: 405-414.","journal-title":"Nat Neurosci"},{"key":"506_CR71","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1523\/JNEUROSCI.1207-08.2008","volume":"28","author":"FX Soriano","year":"2008","unstructured":"Soriano FX, Martel MA, Papadia S, Vaslin A, Baxter P, Rickman C, Forder J, Tymianski M, Duncan R, Aarts M, et al: Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci. 2008, 28: 10696-10710. 10.1523\/JNEUROSCI.1207-08.2008.","journal-title":"J Neurosci"},{"key":"506_CR72","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1523\/JNEUROSCI.2212-09.2009","volume":"29","author":"J Xu","year":"2009","unstructured":"Xu J, Kurup P, Zhang Y, Goebel-Goody SM, Wu PH, Hawasli AH, Baum ML, Bibb JA, Lombroso PJ: Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J Neurosci. 2009, 29: 9330-9343. 10.1523\/JNEUROSCI.2212-09.2009.","journal-title":"J Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-8-175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:27:57Z","timestamp":1630520877000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-8-175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-8-175","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"21 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"175"}}